Google+ COREIM's "ILD and High-Risk Medication Prescribing: Gray Matters Segment" - Tom Wade MD

COREIM’s “ILD and High-Risk Medication Prescribing: Gray Matters Segment”

Today, I review, link to, and excerpt from COREIM‘s ILD and High-Risk Medication Prescribing: Gray Matters Segment.

All that follows is from the above resource.

Posted: February 5, 2025
By: Dr. Alison Trainor, Dr. Kelly Graham, Dr. Rob Hallowell, Jason Krastein and Dr. Jason Freed
Graphic: Dr. Jesse Powell
Audio: Jerome Reyes
Peer Review: Dr. Armand M. Gottlieb, Dr. Robert Koichiro Arao

Podcast: Play in new window | Download

Time Stamps

  • 01:30 Deep Dive 1: Evaluating Incidental Findings
  • 06:45 Deep Dive 2: Categorizing ILD
  • 12:42 Deep Dive 3: Treatment for ILD
  • 21:19 Deep Dive 4: Addressing Barriers to Care
  • 28:10 Deep Dive 5: Ethical Considerations in ILD Treatment

Show Notes

Deep Dive 1: Evaluating Incidental Findings

Why do incidental CT findings matter?

  • Subtle interstitial changes on a CT scan may indicate early fibrosis, atelectasis, aspiration, pulmonary edema, or infection. (Though not exhaustive list)
  • What is  ILD protocol CT?
    • High-resolution CT (HRCT) with inspiratory, expiratory, supine and prone images
    • Differentiate fibrosis from mimics
    • Involves:
      • Number of Acquisitions:
        • Supine Position: Inspiratory (volumetric) and expiratory (sequential or volumetric) acquisitions.
        • Prone Position (Optional): Only inspiratory scans, which can be sequential or volumetric.
        • Inspiratory scans should be obtained at full inspiration.

If fibrosis is suspected:

 

 

This entry was posted in Core IM, CoreIM, Interstitial Lung Disease, Pulmonology. Bookmark the permalink.